World Journal of Biological Psychiatry

Papers
(The H4-Index of World Journal of Biological Psychiatry is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood78
The biology of burnout: Causes and consequences55
Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance43
The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe41
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?38
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders37
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders36
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis35
Personalising transcranial magnetic stimulation for depression using neuroimaging: A systematic review33
Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyl30
Lifetime and current depression in the German National Cohort (NAKO)23
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD23
Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia20
Microglia and HPA axis in depression: An overview of participation and relationship19
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants19
Correlation between S100B and severity of depression in MDD: A meta-analysis16
Circulating cell-free mitochondrial DNA in brain health and disease: A systematic review and meta-analysis16
0.019439935684204